[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597050":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":10,"responsibleParty":26,"collaborators":10,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":34,"eligibilityCriteria":35,"healthyVolunteers":30,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":10},{"fullName":5,"class":6},"Nottingham University Hospitals NHS Trust","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"HBsAg positive",null,"Adult migrant populations living with chronic hepatitis B virus",[13],{"name":14,"affiliation":15,"role":16},"Kathryn E Jack, PhD","NUH","PRINCIPAL_INVESTIGATOR",[18,22],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","+447976243189","kathryn.jack@nhs.net",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Stephen D Ryder, consultant","+44115 924 9924","stephen.ryder4@nhs.net",{"type":27,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100597050","the-impact-of-treatment-for-chronic-hepatitis-b-virus-on-non-clinical-harms-100597050",false,"NCT07053449","The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms","The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical (Social) Harms Amongst Migrant Populations: A Qualitative Study. (B-SOCIAL)","B-SOCIAL","Inclusion Criteria:\n\n* Chronic HBsAg\n* Able to give informed consent in English\n* Able to converse in English\n* Any migrant population member (non-UK) including if born overseas or in the UK\n* Aged 18 years and over\n* Has never taken antiviral treatment for HBV (12-15 participants)\n* Prescribed and taking any oral treatment for HBV for a minimum of 12 months (12-15 participants)\n\nExclusion Criteria:\n\n* Emotionally distressed due to HBV diagnosis\n* Current episode of decompensated cirrhosis\n* Current diagnosis of hepatocellular carcinoma","ALL","18 Years",{"count":39,"type":40},30,"ESTIMATED","OBSERVATIONAL","The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by migrant populations living in the UK.\n\nTwo groups of participants living with hepatitis B virus will be interviewed, those taking the daily treatment, and those not prescribed any treatment.",[44],"Hepatitis B Virus (HBV)",[46,47,48,49],"Hepatitis B Virus","Qualitative","Lived Experience","Stigma","NOT_YET_RECRUITING","2025-07-11",{"date":53,"type":54},"2025-07-16","ACTUAL",{"date":56,"type":40},"2025-08",{"date":58,"type":40},"2026-03",{"name":5,"class":6}]